Novo Nordisk’s Obesity Franchise Expands Reach as Comorbidity Data and Pipeline Catalysts Converge
Semaglutide reduces asthma exacerbations by 26% and migraine medication use by 7%. Stock rebounds 13% in 30 days;…
Browsing Tag